TetOS-dnMAML-GFP transgenic mice allow Tet-Off/Tet-On expression of a dominant negative form of MAML, and may be may be useful for temporally-controlled, tissue-specific blockade of Notch signaling.
Aly Karsan, University of British Columbia, British Columbia Cancer Research Centre
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Reporter, Inducible, Dominant negative, Inserted expressed sequence) |
The TetOS-dnMAML-GFP transgene has the Tet response element (TRE) upstream of a cDNA sequence encoding a dominant-negative mutant variant of human Mastermind-like 1 (dnMAML) fused in-frame at its C-terminus to an enhanced green fluorescent protein (EGFP). The dnMAML-GFP fusion protein [also called DNMAML1-GFP or MAML1(13-74)-GFP] interrupts transactivation/nuclear activity of all four Notch receptors by binding the Notch-CSL [CBF1/Su(H)/Lag2 protein] transcriptional complex, but does not bind the coactivators required for transcription of target genes.
Mice homozygous for the TetOS-dnMAML-GFP transgene are viable and fertile with no reported phenotypic abnormalities. When bred with other mice expressing tetracycline-controlled transactivator protein (tTA) or reverse tetracycline-controlled transactivator protein (rtTA), dnMAML-GFP expression in the resulting double mutant offspring can be regulated with tetracycline or its analog doxycycline (dox). When tTA or rtTA(+dox) is present, dnMAML expression blocks the transactivation/nuclear activity of all four Notch genes by binding to the Notch-CSL [CBF1/Su(H)/Lag2 protein] transcriptional complex (preventing Notch-CSL from binding its endogenous coactivator, MAML), and results in a Notch quadruple knockout in the tTA-expressing cells. GFP expression be observed by direct/native fluorescence and antibody staining/immunohistochemistry (the donating investigator did not attempt mRNA (in situ) hybridization). As designed, TetOS-dnMAML-GFP transgenic mice have no reported levels of dnMAML-GFP expression in the absence of tTA.
These TetOS-dnMAML-GFP transgenic mice allow Tet-Off/Tet-On expression of a dominant negative form of MAML, and may be may be useful for temporally-controlled, tissue-specific blockade of Notch signaling. For example, when bred to a strain expressing tTA in blood vessel endothelial cells (VEtTA: Stock No. 013585), the resulting double mutant mice are useful for identifying Notch target genes in endothelial-to-mesenchymal transdifferentiation in cardiac development.
The TetOS-dnMAML-GFP transgene was designed with a TetOS promoter followed by a cDNA sequence encoding the dnMAML-GFP fusion protein and an SV40 polyA sequence. The TetOS promoter (Tet response element or TRE) contains seven copies of the 42-bp tet operator sequence (tetO) just upstream of a minimal CMV promoter. The dnMAML-GFP cDNA sequence encodes an N-terminal, 62 amino acid (amino acids 13-74), dominant-negative mutant variant of human Mastermind-like 1 (dnMAML) fused in-frame at its C-terminus to an enhanced green fluorescent protein (EGFP). The ~3.0 kbp TetOS-dnMAML-GFP transgene was injected into the pronucleus of ICR oocytes fertilized by ICR males. Founder mice were bred with ICR mice to establish founder line 2. The colony was maintained by breeding TetOS-dnMAML-GFP transgenic mice with ICR mice for several generations, and then by breeding TetOS-dnMAML-GFP transgenic mice with CD-1 outbred mice for several generations prior to sending males to The Jackson Laboratory Repository in 2013. Upon arrival, males were used to cryopreserve sperm. To establish the living mouse colony, an aliquot of the frozen sperm was used to fertilize oocytes from C57BL/6J female mice (Stock No. 000664).
Expressed Gene | MAML1, mastermind like transcriptional coactivator 1, human |
---|---|
Expressed Gene | GFP, Green Fluorescent Protein, |
Site of Expression | These transgenic mice allow Tet-Off/Tet-On expression of a dominant negative form of MAML, and may be may be useful for temporally-controlled, tissue-specific blockade of Notch signaling. For example, when bred to a strain expressing tTA in blood vessel endothelial cells the resulting double mutant mice are useful for identifying Notch target genes in endothelial-to-mesenchymal transdifferentiation in cardiac development. |
Allele Name | transgene insertion 2, Aly Karsan |
---|---|
Allele Type | Transgenic (Reporter, Inducible, Dominant negative, Inserted expressed sequence) |
Allele Synonym(s) | dnMAML-GFP; TetOS-dnMAML-GFP; TetOS-dnMAML |
Gene Symbol and Name | Tg(tetO-MAML1*/EGFP)2Akar, transgene insertion 2, Aly Karsan |
Gene Synonym(s) | |
Promoter | tetO, tet operator, |
Expressed Gene | MAML1, mastermind like transcriptional coactivator 1, human |
Expressed Gene | GFP, Green Fluorescent Protein, |
Site of Expression | These transgenic mice allow Tet-Off/Tet-On expression of a dominant negative form of MAML, and may be may be useful for temporally-controlled, tissue-specific blockade of Notch signaling. For example, when bred to a strain expressing tTA in blood vessel endothelial cells the resulting double mutant mice are useful for identifying Notch target genes in endothelial-to-mesenchymal transdifferentiation in cardiac development. |
Strain of Origin | ICR |
Chromosome | UN |
Molecular Note | The Tet |
When maintaining a live colony, transgenic mice may be bred with wildtype (noncarrier) mice from the colony.
When using the TetOS-dnMAML-GFP mouse strain in a publication, please cite the originating article(s) and include JAX stock #017918 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(tetO-MAML1*/EGFP)2Akar |
Frozen Mouse Embryo | STOCK Tg(tetO-MAML1*/EGFP)2Akar/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(tetO-MAML1*/EGFP)2Akar/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(tetO-MAML1*/EGFP)2Akar/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | STOCK Tg(tetO-MAML1*/EGFP)2Akar/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.